Supplemental material
Open access
678
Views
0
CrossRef citations to date
0
Altmetric
Research Article
Longitudinal analysis of serum neurofilament light chain levels as marker for neuronal damage in hereditary transthyretin amyloidosis
Milou Berendsa Department of Internal Medicine, University Medical Center Groningen, Groningen, The Netherlands;b Amyloidosis Center of Expertise, University Medical Center Groningen, Groningen, The NetherlandsCorrespondence[email protected]
View further author information
, View further author information
Anne F. Brungerb Amyloidosis Center of Expertise, University Medical Center Groningen, Groningen, The Netherlands;c Department of Rheumatology & Clinical Immunology, University Medical Center Groningen, Groningen, The NetherlandsView further author information
, Johan Bijzetb Amyloidosis Center of Expertise, University Medical Center Groningen, Groningen, The Netherlands;d Department of Laboratory Medicine, University Medical Center Groningen, Groningen, The NetherlandsView further author information
, Bart-Jan Kroesenb Amyloidosis Center of Expertise, University Medical Center Groningen, Groningen, The Netherlands;d Department of Laboratory Medicine, University Medical Center Groningen, Groningen, The NetherlandsView further author information
, Gea Drostb Amyloidosis Center of Expertise, University Medical Center Groningen, Groningen, The Netherlands;e Department of Neurology, University Medical Center Groningen, Groningen, The NetherlandsView further author information
, Fiete Langeb Amyloidosis Center of Expertise, University Medical Center Groningen, Groningen, The Netherlands;e Department of Neurology, University Medical Center Groningen, Groningen, The NetherlandsView further author information
, Charlotte E. Teunissenf Department of Laboratory Medicine, Amsterdam Neuroscience, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The NetherlandsView further author information
, Sjors in ‘t Veldf Department of Laboratory Medicine, Amsterdam Neuroscience, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The NetherlandsView further author information
, Alexander FJE Vranckeng Department of Neurology, University Medical Center Utrecht, Utrecht, The NetherlandsView further author information
, Reinold O. B. Gansa Department of Internal Medicine, University Medical Center Groningen, Groningen, The Netherlands;b Amyloidosis Center of Expertise, University Medical Center Groningen, Groningen, The NetherlandsView further author information
, Bouke P. C. Hazenbergb Amyloidosis Center of Expertise, University Medical Center Groningen, Groningen, The Netherlands;c Department of Rheumatology & Clinical Immunology, University Medical Center Groningen, Groningen, The Netherlandshttps://orcid.org/0000-0003-1827-0482View further author information
, Paul A. van der Zwaagb Amyloidosis Center of Expertise, University Medical Center Groningen, Groningen, The Netherlands;h Department of Medical Genetics, University Medical Center Groningen, Groningen, The NetherlandsView further author information
& Hans L. A. Nienhuisa Department of Internal Medicine, University Medical Center Groningen, Groningen, The Netherlands;b Amyloidosis Center of Expertise, University Medical Center Groningen, Groningen, The NetherlandsView further author information
show all
Received 14 Nov 2023, Accepted 29 Feb 2024, Published online: 13 Mar 2024
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.